Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1125.00Today’s High
1173.0052W low
956.7052W High
1850.00Open Price
1130.00Prev. Close
1016.3500Volume
72429.00Value
83937968.10Fundamentals
Market Cap Cr
2710.90
Price to Earnings
89.30
Price to Book Value
3.70
Dividend Yield
0.20
PE to Growth
-2.70
Op Revenue TTM Cr
393.50
Net Profit TTM Cr
30.35
Cash From Operating Activity Cr
98.04
Return on Equity %
4.11
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
49.4
Week
46.9
Month
51.5
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1152.30
PIVOT
First Resistance
1179.60
Second Resistance
1200.30
Third Resistance
1227.60
First Support
1131.60
Second Support
1104.30
Third Support
1083.60
Relative Strength Index
63.25
Money Flow Index
83.09
MACD
14.55
MACD Signal
3.85
Average True Range
40.73
Average Directional Index
35.7
Rate of Change (21)
16.42
Rate of Change (125)
-27.11
Commodity Channel Index
94.6
Williams %R
-30.9
BETA
1 Month
0.24
3 Month
0.24
1 Year
0.22
3 Year
PRICE CHANGE ANALYSIS
↑ 3%
1 Week
Low
High
1084.45
1173
↑ 13.34%
1 Month
Low
High
956.7
1222
↓ -4.93%
3 Months
Low
High
956.7
1320
↓ -27.11%
6 Months
Low
High
956.7
1612.1
↓ -36.23%
1 Year
Low
High
956.7
1850
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 98.46 | 87.28 | 93.33 | 107.12 | 120.19 | 114.61 | 85.59 | 87.89 | 103.07 | 106.67 | 119.28 | |
| Operating Expenses Qtr | 79.73 | 73.76 | 71.83 | 86.49 | 104.00 | 96.69 | 75.11 | 72.57 | 79.78 | 78.83 | 82.45 | |
| Operating Profit Qtr | 14.20 | 12.31 | 20.74 | 19.61 | 15.40 | 16.85 | 8.93 | 13.50 | 22.10 | 22.76 | 34.24 | |
| EBIDT Qtr Cr | 18.73 | 13.52 | 21.50 | 20.63 | 12.60 | 17.92 | 10.48 | 15.33 | 23.29 | 27.84 | 36.83 | |
| Depreciation Qtr | 6.23 | 6.58 | 6.78 | 6.01 | 2.53 | 2.38 | 2.31 | 2.33 | 2.15 | 2.08 | 2.06 | |
| Net Profit Qtr | 8.25 | 4.65 | 8.20 | 8.25 | 16.15 | 10.56 | 5.26 | 8.50 | 18.89 | 22.43 | 30.72 | |
| Basic EPS Qtr | 3.52 | 1.99 | 3.63 | 3.72 | 7.29 | 4.76 | 2.37 | 3.83 | 8.52 | 10.12 | 14.24 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 386.19 | 408.72 | 438.32 | 296.29 | 254.40 | |
| Operating Expenses Annual Cr | 311.81 | 348.37 | 322.04 | 226.00 | 201.45 | |
| Operating Profit Annual | 66.86 | 54.68 | 105.77 | 65.19 | 52.39 | |
| Operating Profit Margin Annual % | 17.31 | 13.38 | 24.13 | 22.00 | 20.59 | |
| Total Expenses Annual Cr | 343.92 | 366.30 | 335.05 | 236.94 | 210.19 | |
| EBIDT Annual Cr | 74.37 | 60.36 | 116.28 | 70.28 | 52.95 | |
| EBIDT Annual margin % | 19.26 | 14.77 | 26.53 | 23.72 | 20.81 | |
| Depreciation | 25.60 | 9.55 | 8.18 | 6.73 | 4.79 | |
| PAT Before ExtraOrdinary Items Annual Cr | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 | |
| Net Profit Annual | 29.35 | 40.47 | 95.99 | 51.36 | 34.96 | |
| Basic EPS Annual | 12.82 | 18.26 | 44.65 | 25.57 | 17.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 725.88 | 504.78 | 468.88 | 161.94 | 114.45 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 1.97 | 5.38 | 13.78 | 30.82 | 43.59 | |
| Total Current Liabilities Annual Cr | 87.21 | 244.70 | 169.59 | 116.92 | 87.26 | |
| Total Capital Plus Liabilities Annual Cr | 815.07 | 754.86 | 652.25 | 309.68 | 245.31 | |
| Fixed Assets Annual | 503.40 | 426.97 | 211.10 | 130.26 | 116.07 | |
| Total Non Current Assets Annual | 521.46 | 443.39 | 223.08 | 131.22 | 116.90 | |
| Total Current Assets Annual | 293.61 | 311.47 | 429.17 | 178.46 | 128.40 | |
| Total Assets Annual | 815.07 | 754.86 | 652.25 | 309.68 | 245.31 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 19.19 | 79.05 | 4.11 | 2.68 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 102.78 | 23.73 | 19.89 | 22.75 | 24.64 | |
| Cash from Investing Activity Annual | -120.54 | -101.12 | -196.81 | -20.40 | -40.18 | |
| Cash from Financing Annual Activity | 30.54 | 37.81 | 234.96 | -8.59 | 9.70 | |
| Net Cash Flow Annual | - | -39.58 | 58.05 | -6.23 | -5.85 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 310.31 | 227.74 | 211.54 | 80.61 | 142.44 | |
| ROE Annual % | 4.04 | 8.01 | 20.47 | 31.71 | 30.54 | |
| ROCE Annual % | 6.70 | 9.95 | 22.39 | 32.97 | 30.47 | |
| Total Debt to Total Equity Annual | 0.02 | 0.34 | 0.26 | 0.47 | 0.69 | |
| EBDIT Annual Margin % | 19.64 | 14.97 | 27.17 | 24.13 | 20.85 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 102.79 | 85.42 | 97.42 | 115.38 | 125.36 | 122.13 | 91.64 | 90.23 | 98.89 | 109.39 | 126.42 | |
| Operating Expenses Qtr | 82.66 | 73.21 | 76.42 | 93.02 | 108.24 | 102.69 | 78.91 | 73.19 | 76.58 | 80.86 | 87.72 | |
| Operating Profit Qtr | 15.61 | 10.99 | 20.25 | 21.34 | 16.27 | 17.91 | 11.18 | 15.22 | 21.95 | 23.81 | 35.89 | |
| EBIDT Qtr Cr | 20.14 | 12.20 | 21.00 | 22.36 | 13.53 | 19.43 | 12.73 | 17.05 | 22.30 | 28.53 | 38.70 | |
| Depreciation Qtr | 6.23 | 6.58 | 6.78 | 6.01 | 2.53 | 2.38 | 2.31 | 2.33 | 2.15 | 2.08 | 2.06 | |
| Net Profit Qtr | 9.61 | 3.46 | 7.78 | 9.50 | 16.95 | 11.62 | 7.11 | 9.80 | 17.51 | 22.81 | 32.41 | |
| Basic EPS Qtr | 4.11 | 1.48 | 3.43 | 4.29 | 7.65 | 5.24 | 3.21 | 4.42 | 7.90 | 10.29 | 15.02 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 401.01 | 429.36 | 442.54 | 306.29 | 264.62 | |
| Operating Expenses Annual Cr | 325.31 | 363.03 | 325.41 | 234.66 | 208.29 | |
| Operating Profit Annual | 68.20 | 60.58 | 108.24 | 65.70 | 54.95 | |
| Operating Profit Margin Annual % | 17.01 | 14.11 | 24.46 | 21.45 | 20.77 | |
| Total Expenses Annual Cr | 357.44 | 380.99 | 338.42 | 245.60 | 217.03 | |
| EBIDT Annual Cr | 75.70 | 66.33 | 117.13 | 71.64 | 56.34 | |
| EBIDT Annual margin % | 18.88 | 15.45 | 26.47 | 23.39 | 21.29 | |
| Depreciation | 25.61 | 9.55 | 8.18 | 6.73 | 4.79 | |
| PAT Before ExtraOrdinary Items Annual Cr | 30.35 | 45.49 | 95.87 | 52.26 | 37.79 | |
| Net Profit Annual | 30.35 | 45.49 | 95.87 | 52.26 | 37.79 | |
| Basic EPS Annual | 13.26 | 20.52 | 44.59 | 26.02 | 18.81 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 737.08 | 514.79 | 473.09 | 165.96 | 117.69 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 1.97 | 5.38 | 13.78 | 30.82 | 43.59 | |
| Total Current Liabilities Annual Cr | 79.66 | 236.13 | 171.43 | 118.02 | 87.65 | |
| Total Capital Plus Liabilities Annual Cr | 818.72 | 756.30 | 658.30 | 314.80 | 248.94 | |
| Fixed Assets Annual | 503.42 | 426.99 | 211.10 | 130.26 | 116.07 | |
| Total Non Current Assets Annual | 520.81 | 442.75 | 222.42 | 130.55 | 116.24 | |
| Total Current Assets Annual | 297.91 | 313.56 | 435.88 | 184.25 | 132.70 | |
| Total Assets Annual | 818.72 | 756.30 | 658.30 | 314.80 | 248.94 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 19.19 | 80.05 | 4.14 | 2.70 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 98.04 | 27.78 | 20.38 | 24.32 | 25.31 | |
| Cash from Investing Activity Annual | -120.54 | -101.14 | -196.81 | -21.01 | -40.18 | |
| Cash from Financing Annual Activity | 30.52 | 37.80 | 234.96 | -8.80 | 9.95 | |
| Net Cash Flow Annual | - | -35.56 | 58.54 | -5.49 | -4.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 315.10 | 232.25 | 213.44 | 82.62 | 146.48 | |
| ROE Annual % | 4.11 | 8.83 | 20.26 | 31.48 | 32.10 | |
| ROCE Annual % | 6.77 | 10.91 | 22.37 | 32.98 | 31.95 | |
| Total Debt to Total Equity Annual | 0.02 | 0.33 | 0.25 | 0.46 | 0.67 | |
| EBDIT Annual Margin % | 19.23 | 15.65 | 27.01 | 23.84 | 21.40 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sbi Magnum Midcap Fund | 2.77 | 73809652 | - | - |
| Icici Prudential Smallcap Fund | 2.01 | 73809653 | - | - |
| Goldman Sachs Funds - Goldman Sachs India Equity Portfolio | 2.3 | 73809656 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Shekhar Rasiklal Somani | 23.07 | 73809638 | 0 | 27.38 |
| Chintan Nitinkumar Shah | 20.94 | 73809639 | 0 | 30.17 |
| Ajay Mansukhlal Patel | 17.1 | 73809640 | 0 | 36.94 |
| Priti Ajay Patel | 3.85 | 73809641 | 0 | 0 |
| Ajay Mansukhlal Patel (HUF) | 3.06 | 73809642 | 0 | 0 |
| Chintan N Shah (HUF) | 1.91 | 73809643 | 0 | 0 |
| Shital Chintan Shah | 0.99 | 73809644 | 0 | 0 |
| Kajalben Shekharkumar Somani | 0.93 | 73809645 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Nippon Life India Trustee Ltd-A/C Nippon India Elss Tax Saver Fund | 5.9 | 73809651 |
| Sbi Magnum Midcap Fund | 2.77 | 73809652 |
| Icici Prudential Smallcap Fund | 2.01 | 73809653 |
| Mirae Asset Aggressive Hybrid Fund | 1.64 | 73809654 |
| Goldman Sachs Funds - Goldman Sachs India Equity Portfolio | 2.3 | 73809656 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 08, 2023 | 2 | FINAL | - | Equity Share |
| Sep 08, 2022 | 2 | FINAL | Sep 09, 2022 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 03, 2024 | Audited Results & Final Dividend | - |
| Jan 20, 2024 | Quarterly Results | - |
| Nov 02, 2023 | Quarterly Results | - |
| Aug 04, 2023 | Quarterly Results | - |
| Jul 11, 2023 | Preferential issue of shares | - |
| May 05, 2023 | Audited Results & Final Dividend | - |
| Jan 24, 2023 | Quarterly Results | - |
| Nov 04, 2022 | Quarterly Results | - |
| Jul 25, 2022 | Quarterly Results | - |
| Apr 25, 2022 | Audited Results & Final Dividend | - |
| Jan 17, 2022 | Quarterly Results | - |
| Oct 23, 2021 | Quarterly Results | - |
| Aug 14, 2021 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
26 Jun 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window
Intimation of Closure of Trading Window
22 Jun 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
10 Jun 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
23 May 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31 March 2024 (2023-24).
07 May 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings call held on 03 May 2024 post announcement of the financial results of the Company for the quarter and financial year ended 31 March 2024.
07 May 2024
Tatva Chintan Q4 Results Review - Revenue May Rise 25% With Expansion In Margin: ICICI Securities
Gross profit margin up 215 bps QoQ to 57.8%
04 May 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Extract of Financial Results of the Company for the Quarter and Financial Year Ended 31 March 2024. 
03 May 2024
Tatva Chintan Pharma Q4 Results: Profit Falls 43%
The specialty chemical manufacturer's profit declined to Rs 9.6 crore in the quarter-ended March.
03 May 2024
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for Initial Public Offering ("IPO") for the quarter ended 31 March 2024.
